Cargando…
Stability of Recombinant Tissue Plasminogen Activator at −30 °C Over One Year
Recombinant tissue plasminogen activator (rt-PA) is used to restore patency and avoid inadvertent removal of peripheral and central venous catheters. rt-PA was reconstituted (1 mg/mL) then cryopreserved at −30 °C for 1, 2, 3, 6, 8, and 12 months and, then its stability was determined. After cryopres...
Autor principal: | Alkatheri, Abdulmalik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816680/ https://www.ncbi.nlm.nih.gov/pubmed/24275785 http://dx.doi.org/10.3390/ph6010025 |
Ejemplares similares
-
Long-term stability of recombinant tissue plasminogen activator at -80 C
por: Shaw, George J, et al.
Publicado: (2009) -
Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator for Ischemic Stroke Patients over 80 Years Old: The Fukuoka Stroke Registry
por: Matsuo, Ryu, et al.
Publicado: (2014) -
Recombinant tissue plasminogen activator in the treatment of suprachoroidal hemorrhage
por: Kunjukunju, Nancy, et al.
Publicado: (2011) -
Tissue Plasminogen Activator Neurotoxicity is Neutralized by Recombinant ADAMTS 13
por: Fan, Mengchen, et al.
Publicado: (2016) -
Recombinant tissue plasminogen activator plus heparin compared with heparin alone for patients with acute submassive pulmonary embolism: one-year outcome
por: Mi, Yu-Hong, et al.
Publicado: (2013)